VidhiAagaz
International Journal ofLaw Management & Humanities
ISSN 2581-5369 · Open access
International Journal ofLaw Management & Humanities
Open accessResearch PaperVol. 4 No. V (2021)pp. 831–843

Prudent Use of Compulsory Licensing, Voluntary Licensing and TRIPS waiver in the wake of Covid -19 pandemic: An Indian Perspective

GP
Dr. Geni PhiliposeAssistant Professor at School of Law, Hindustan Institute of Technology and Science, India
View PDF
1,133views767downloads
Published 25 September 2021 · pp. 831–843 · Vol. 4 No. V (2021)
Abstract

The Covid -19 pandemic has changed the lives of many because of its devastating effect. The unprecedented demand for life-saving drugs, equipment needed to save lives has put pressure on every country’s ability to manufacture these essentials on a large scale. People have to be vaccinated to prevent people from being infected. Thus, the nations are exploring various methods to procure and manufacture these vaccines, medicines, and equipment to meet the needs of their citizens. In a vast country like India, the demand is immensely high. This article explores various options India have, such as Compulsory Licensing, Voluntary Licensing, and asking for a TRIPS waiver, in order to procure and manufacture vaccines and medicines.

Keywords
Covid-19Compulsory LicensingVoluntary LicencingTRIPS waiverPatent

How to cite

Dr. Geni Philipose, Prudent Use of Compulsory Licensing, Voluntary Licensing and TRIPS waiver in the wake of Covid -19 pandemic: An Indian Perspective, 4 Int'l J. L. Mgmt. & Human. 831 (2021).

Cite this article

Dr. Geni Philipose, Prudent Use of Compulsory Licensing, Voluntary Licensing and TRIPS waiver in the wake of Covid -19 pandemic: An Indian Perspective, 4 Int'l J. L. Mgmt. & Human. 831 (2021).
Chat with us